CD8+ cytotoxic T lymphocytes (CTLs) play an important role in containment of virus replication in primary human immunodeficiency virus (HIV) infection. HIV's ability to mutate to escape from CTL pressure is increasingly recognized; but comprehensive studies of escape from the CD8 T cell response in primary HIV infection are currently lacking. Here, we have fully characterized the primary CTL response to autologous virus Env, Gag, and Tat proteins in three patients, and investigated the extent, kinetics, and mechanisms of viral escape from epitope-specific components of the response. In all three individuals, we observed variation beginning within weeks of infection at epitope-containing sites in the viral quasispecies, which conferred escape by mechanisms including altered peptide presentation/recognition and altered antigen processing. The number of epitope-containing regions exhibiting evidence of early CTL escape ranged from 1 out of 21 in a subject who controlled viral replication effectively to 5 out of 7 in a subject who did not. Evaluation of the extent and kinetics of HIV-1 escape from >40 different epitope-specific CD8 T cell responses enabled analysis of factors determining escape and suggested that escape is restricted by costs to intrinsic viral fitness and by broad, codominant distribution of CTL-mediated pressure on viral replication.
Skip Nav Destination
Article navigation
15 November 2004
Article|
November 15 2004
Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response
Nicola A. Jones,
Nicola A. Jones
1Viral Immunology Group, The Edward Jenner Institute for Vaccine Research, Compton, Berkshire RG20 7NN, England, UK
Search for other works by this author on:
Xiping Wei,
Xiping Wei
3Howard Hughes Medical Institute, University of Alabama at Birmingham, Birmingham, AL 35294
Search for other works by this author on:
Darren R. Flower,
Darren R. Flower
2Bioinformatics Group, The Edward Jenner Institute for Vaccine Research, Compton, Berkshire RG20 7NN, England, UK
Search for other works by this author on:
MaiLee Wong,
MaiLee Wong
1Viral Immunology Group, The Edward Jenner Institute for Vaccine Research, Compton, Berkshire RG20 7NN, England, UK
Search for other works by this author on:
Franziska Michor,
Franziska Michor
6Program in Theoretical Biology and Evolutionary Dynamics, Harvard University, Cambridge, MA 02138
7Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138
8Department of Mathematics, Harvard University, Cambridge, MA 02138
Search for other works by this author on:
Michael S. Saag,
Michael S. Saag
4Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
5Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294
Search for other works by this author on:
Beatrice H. Hahn,
Beatrice H. Hahn
4Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
5Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294
Search for other works by this author on:
Martin A. Nowak,
Martin A. Nowak
6Program in Theoretical Biology and Evolutionary Dynamics, Harvard University, Cambridge, MA 02138
7Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138
8Department of Mathematics, Harvard University, Cambridge, MA 02138
Search for other works by this author on:
George M. Shaw,
George M. Shaw
3Howard Hughes Medical Institute, University of Alabama at Birmingham, Birmingham, AL 35294
4Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
5Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294
Search for other works by this author on:
Persephone Borrow
Persephone Borrow
1Viral Immunology Group, The Edward Jenner Institute for Vaccine Research, Compton, Berkshire RG20 7NN, England, UK
Search for other works by this author on:
Nicola A. Jones
1Viral Immunology Group, The Edward Jenner Institute for Vaccine Research, Compton, Berkshire RG20 7NN, England, UK
Xiping Wei
3Howard Hughes Medical Institute, University of Alabama at Birmingham, Birmingham, AL 35294
Darren R. Flower
2Bioinformatics Group, The Edward Jenner Institute for Vaccine Research, Compton, Berkshire RG20 7NN, England, UK
MaiLee Wong
1Viral Immunology Group, The Edward Jenner Institute for Vaccine Research, Compton, Berkshire RG20 7NN, England, UK
Franziska Michor
6Program in Theoretical Biology and Evolutionary Dynamics, Harvard University, Cambridge, MA 02138
7Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138
8Department of Mathematics, Harvard University, Cambridge, MA 02138
Michael S. Saag
4Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
5Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294
Beatrice H. Hahn
4Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
5Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294
Martin A. Nowak
6Program in Theoretical Biology and Evolutionary Dynamics, Harvard University, Cambridge, MA 02138
7Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138
8Department of Mathematics, Harvard University, Cambridge, MA 02138
George M. Shaw
3Howard Hughes Medical Institute, University of Alabama at Birmingham, Birmingham, AL 35294
4Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
5Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294
Persephone Borrow
1Viral Immunology Group, The Edward Jenner Institute for Vaccine Research, Compton, Berkshire RG20 7NN, England, UK
Address correspondence to Persephone Borrow, Viral Immunology Group, The Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire RG20 7NN, England, UK. Phone: 44-1635-577913; Fax: 44-1635-577901; email: [email protected]
Abbreviations used in this paper: β-gal, β-galactosidase; DFOSx, days following onset of symptoms; NAb, neutralizing antibody; rVV, recombinant vaccinia virus.
Received:
March 17 2004
Accepted:
September 13 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 200 (10): 1243–1256.
Article history
Received:
March 17 2004
Accepted:
September 13 2004
Citation
Nicola A. Jones, Xiping Wei, Darren R. Flower, MaiLee Wong, Franziska Michor, Michael S. Saag, Beatrice H. Hahn, Martin A. Nowak, George M. Shaw, Persephone Borrow; Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response . J Exp Med 15 November 2004; 200 (10): 1243–1256. doi: https://doi.org/10.1084/jem.20040511
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement